We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VIR market cap is 1.1B. The company's latest EPS is USD -4.5549 and P/E is -1.78.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 374.56M | 49.41M | 62.96M | 3.8M | 2.64M |
| Operating Income | 194.96M | -150.5M | -143.37M | -215.19M | -186.73M |
| Net Income | 175.31M | -101.6M | -140.9M | -194.78M | -163.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 8.09M | 76.37M | 1.1B | 1.62B | 86.18M |
| Operating Income | -177.98M | -296.98M | 420.75M | 833.07M | -676.61M |
| Net Income | -174.68M | -298.67M | 528.58M | 515.84M | -615.06M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.7B | 2.8B | 2.67B | 2.24B | 2.04B |
| Total Liabilities | 546.12M | 724.13M | 695.14M | 433.67M | 369.81M |
| Total Equity | 2.15B | 2.08B | 1.97B | 1.81B | 1.68B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 512.07M | 918.76M | 1.95B | 2.8B | 1.92B |
| Total Liabilities | 88.13M | 201.91M | 522.42M | 724.13M | 328.82M |
| Total Equity | 423.94M | 716.85M | 1.43B | 2.08B | 1.59B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.63B | 1.66B | -125.78M | -515.03M | -670.86M |
| Investing | -1.04B | -1.19B | 98.08M | 328.39M | 269.44M |
| Financing | 32.75M | 34.76M | 2.34M | 5.52M | 5.8M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -129.63M | -190.94M | -47.59M | 1.66B | -778.79M |
| Investing | -256.16M | -9.86M | -140.81M | -1.19B | 164.63M |
| Financing | 449.24M | 529.47M | 100.33M | 34.76M | 7.48M |
| Market Cap | 1.1B |
| Price to Earnings Ratio | -1.78 |
| Price to Sales Ratio | 12.72 |
| Price to Cash Ratio | 4.54 |
| Price to Book Ratio | 0.69 |
| Dividend Yield | - |
| Shares Outstanding | 135.03M |
| Average Volume (1 week) | 928.16k |
| Average Volume (1 Month) | 827.28k |
| 52 Week Change | -68.59% |
| 52 Week High | 27.48 |
| 52 Week Low | 7.72 |
| Spread (Intraday) | 0.97 (10.81%) |
| Company Name | Vir Biotechnology Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.vir.bio |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
